Pro-opiomelanocortin (POMC)-derived peptides and the regulation of energy homeostasis

Molecular and Cellular Endocrinology

Volumn 300, Issue 1-2, 2009, Pages 147-151

  Coll, Anthony P ^a   Loraine Tung, Y C ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Dietary preference; Glucocorticoids; Obesity; POMC

Indexed keywords

AGOUTI RELATED PROTEIN; CORTICOSTERONE; FAT; GLUCOCORTICOID; MELANOCORTIN; PROOPIOMELANOCORTIN;

DISEASE PREDISPOSITION; ENERGY BALANCE; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME DEFICIENCY; GENE; HOMEOSTASIS; HOMEOSTASIS AND REGULATION; HUMAN; HYPERPHAGIA; INSULIN RESISTANCE; LIPID DIET; METABOLIC REGULATION; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVIEW; RISK FACTOR;

ANIMALS; DIET; ENERGY METABOLISM; FOOD; FOOD PREFERENCES; GLUCOCORTICOIDS; HOMEOSTASIS; HUMANS; MELANOCORTINS; MELANOCYTE-STIMULATING HORMONES; PEPTIDES; PRO-OPIOMELANOCORTIN; PROTEIN ISOFORMS;

EID: 59649096208     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2008.09.007     Document Type: Review

References (28)

1. Biebermann H., Castaneda T.R., van Landeghem F., von Deimling A., Escher F., Brabant G., Hebebrand J., Hinney A., Tschop M.H., Gruters A., and Krude H. A role for beta-melanocyte-stimulating hormone in human body-weight regulation. Cell Metab. 3 (2006) 141-146
2. Coll A.P., Farooqi I.S., and O'Rahilly S. The hormonal control of food intake. Cell 129 (2007) 251-262
3. Challis B.G., Coll A.P., Yeo G.S., Pinnock S.B., Dickson S.L., Thresher R.R., Dixon J., Zahn D., Rochford J.J., White A., Oliver R.L., Millington G., Aparicio S.A., Colledge W.H., Russ A.P., Carlton M.B., and O'Rahilly S. Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3-36). Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 4695-4700
4. Candille S.I., Kaelin C.B., Cattanach B.M., Yu B., Thompson D.A., Nix M.A., Kerns J.A., Schmutz S.M., Millhauser G.L., and Barsh G.S. A-defensin mutation causes black coat color in domestic dogs. Science 318 (2007) 1418-1423
5. Cooper S.J., Barber D.J., and Barbour-McMullen J. Selective attenuation of sweetened milk consumption by opiate receptor antagonists in male and female rats of the Roman strains. Neuropeptides 5 (1985) 349-352
6. Cai G., Cole S.A., Bastarrachea-Sosa R.A., Maccluer J.W., Blangero J., and Comuzzie A.G. Quantitative trait locus determining dietary macronutrient intakes is located on human chromosome 2p22. Am. J. Clin. Nutr. 80 (2004) 1410-1414
7. Comuzzie A.G., Hixson J.E., Almasy L., Mitchell B.D., Mahaney M.C., Dyer T.D., Stern M.P., MacCluer J.W., and Blangero J. A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2. Nat. Genet. 15 (1997) 273-276
8. Coll A.P., Challis B.G., Lopez M., Piper S., Yeo G.S., and O'Rahilly S. Proopiomelanocortin-deficient mice are hypersensitive to the adverse metabolic effects of glucocorticoids. Diabetes 54 (2005) 2269-2276
9. Drazen D.L., Wortman M.D., Schwartz M.W., Clegg D.J., van Dijk G., Woods S.C., and Seeley R.J. Adrenalectomy alters the sensitivity of the central nervous system melanocortin system. Diabetes 52 (2003) 2928-2934
10. Farooqi I.S., Drop S., Clements A., Keogh J.M., Biernacka J., Lowenbein S., Challis B.G., and O'Rahilly S. Heterozygosity for a POMC-null mutation and increased obesity risk in humans. Diabetes 55 (2006) 2549-2553
11. Hagan M.M., Rushing P.A., Benoit S.C., Woods S.C., and Seeley R.J. Opioid receptor involvement in the effect of AgRP-(83-132) on food intake and food selection. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280 (2001) R814-R821
12. Hixson J.E., Almasy L., Cole S., Birnbaum S., Mitchell B.D., Mahaney M.C., Stern M.P., MacCluer J.W., Blangero J., and Comuzzie A.G. Normal variation in leptin levels in associated with polymorphisms in the proopiomelanocortin gene POMC. J. Clin. Endocrinol. Metab. 84 (1999) 3187-3191
13. Haskell-Luevano C., and Monck E.K. Agouti-related protein functions as an inverse agonist at a constitutively active brain melanocortin-4 receptor. Regul. Pept. 99 (2001) 1-7
14. Krude H., Biebermann H., Luck W., Horn R., Brabant G., and Gruters A. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat. Genet. 19 (1998) 155-157
15. Krude H., Biebermann H., Schnabel D., Tansek M.Z., Theunissen P., Mullis P.E., and Gruters A. Obesity due to proopiomelanocortin deficiency: three new cases and treatment trials with thyroid hormone and ACTH4-10. J. Clin. Endocrinol. Metab. 88 (2003) 4633-4640
16. Koegler F.H., Schaffhauser R.O., Mynatt R.L., York D.A., and Bray G.A. Macronutrient diet intake of the lethal yellow agouti (Ay/a) mouse. Physiol. Behav. 67 (1999) 809-812
17. Lee Y.S., Challis B.G., Thompson D.A., Yeo G.S., Keogh J.M., Madonna M.E., Wraight V., Sims M., Vatin V., Meyre D., Shield J., Burren C., Ibrahim Z., Cheetham T., Swift P., Blackwood A., Hung C.C., Wareham N.J., Froguel P., Millhauser G.L., O'Rahilly S., and Farooqi I.S. A POMC variant implicates beta-melanocyte-stimulating hormone in the control of human energy balance. Cell Metab. 3 (2006) 135-140
18. Makimura H., Mizuno T.M., Roberts J., Silverstein J., Beasley J., and Mobbs C.V. Adrenalectomy reverses obese phenotype and restores hypothalamic melanocortin tone in leptin-deficient ob/ob mice. Diabetes 49 (2000) 1917-1923
19. Michailidou Z., Coll A.P., Kenyon C.J., Morton N.M., O'Rahilly S., Seckl J.R., and Chapman K.E. Peripheral mechanisms contributing to the glucocorticoid hypersensitivity in proopiomelanocortin null mice treated with corticosterone. J. Endocrinol. 194 (2007) 161-170
20. Nijenhuis W.A., Oosterom J., and Adan R.A. AgRP(83-132) acts as an inverse agonist on the human-melanocortin-4 receptor. Mol. Endocrinol. 15 (2001) 164-171
21. Smart J.L., Tolle V., and Low M.J. Glucocorticoids exacerbate obesity and insulin resistance in neuron-specific proopiomelanocortin-deficient mice. J. Clin. Invest. 116 (2006) 495-505
22. Samama P., Rumennik L., and Grippo J.F. The melanocortin receptor MCR4 controls fat consumption. Regul. Pept. 113 (2003) 85-88
23. Slieker L.J., Sloop K.W., Surface P.L., Kriauciunas A., LaQuier F., Manetta J., Bue-Valleskey J., and Stephens T.W. Regulation of expression of ob mRNA and protein by glucocorticoids and cAMP. J. Biol. Chem. 271 (1996) 5301-5304
24. Smart J.L., and Low M.J. Lack of proopiomelanocortin peptides results in obesity and defective adrenal function but normal melanocyte pigmentation in the murine C57BL/6 genetic background. Ann. N Y Acad. Sci. 994 (2003) 202-210
25. Tung Y.C., Rimmington D., O'Rahilly S., and Coll A.P. Pro-opiomelanocortin modulates the thermogenic and physical activity responses to high-fat feeding and markedly influences dietary fat preference. Endocrinology 148 (2007) 5331-5338
26. Tung Y.C., Piper S.J., Yeung D., O'Rahilly S., and Coll A.P. A comparative study of the central effects of specific proopiomelancortin (POMC)-derived melanocortin peptides on food intake and body weight in pomc null mice. Endocrinology 147 (2006) 5940-5947
27. Yaswen L., Diehl N., Brennan M.B., and Hochgeschwender U. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat. Med. 5 (1999) 1066-1070
28. Xu A.W., Kaelin C.B., Morton G.J., Ogimoto K., Stanhope K., Graham J., Baskin D.G., Havel P., Schwartz M.W., and Barsh G.S. Effects of hypothalamic neurodegeneration on energy balance. PLoS Biol. 3 (2005) e415